BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

BIOREGENX, INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026

$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $3.88M
P/E (TTM): –
Dividend yield: –

Dividends

Bioregenx has not reported a dividend

No dividend per share appears in Bioregenx's annual filings since fiscal 2020.

Where these numbers come from

Parsed from the XBRL in Bioregenx's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Mar 25, 2011
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BRGX.

Revenue growth-23.4% · median 7.8%

Gross margin81.9% · median 30.1%

Operating margin-62.4% · median -40.3%

Net margin-73.8% · median -37.9%

Company	Revenue	Growth
BHIC	$4.49M	+7.8%
CNET	$3.45M	-55.1%
KOAN	$2.23M	+2100.9%
BRGX	$1.77M	-23.4%
UMEW	$1.04M	–
KNRX	–	–

Company

Exchange: OTC
Industry: Services-Computer Programming, Data Processing, Etc.
Fiscal year ends: December 31
Employees: 6
Auditor: Weinberg & Company, P.A.
SEC CIK: 1593184

Advertisement
300 × 250